Current Use of Selective Serotonin Reuptake Inhibitors and Risk of Acute Myocardial Infarction

By Raymond G. Schlienger   Lorenz M. Fischer  

Drug Safety, Vol. 27, Iss. 14, 2004-01 ,pp. : 1157-1165

Adis International

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors and Cytochrome P-450 Mediated Drug-Drug Interactions: An Update

By  

Current Drug Metabolism, Vol. 3, Iss. 1, 2002-02 ,pp. : 13-37

Bentham Science Publishers

Access to resources Recommend Favorite

Studies of four novel diphenylbutylpiperazinepyridyl derivatives on release and inhibition of reuptake of dopamine, serotonin and noradrenaline by rat brain in vitro

By Pettersson E.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 131-135

Elsevier

Access to resources Recommend Favorite

Risk of Upper Gastrointestinal Bleeding and the Degree of Serotonin Reuptake Inhibition by Antidepressants: A Case-Control Study

By Vidal Xavier   Ibáñez Luisa   Vendrell Lourdes   Conforti Ana   Laporte Joan-Ramon  

Drug Safety, Vol. 31, Iss. 2, 2008-01 ,pp. : 159-168

Adis International

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors in Pregnancy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4554-4561

Bentham Science Publishers

Access to resources Recommend Favorite